Interim MRD May Help Direct Individual Treatment for CLL
Achieving undetectable MRD after chemoimmunotherapy predicted longer progression-free and overall survival in CLL patients.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Tags: Chronic Lymphocytic Leukemia Hematologic Malignancies News Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Legislation | Leukemia